Product image of Monofer (Ferric Derisomaltose) supplied by GNH India

Monofer

Active Ingredient:
Ferric Derisomaltose
Origin:
EU

Monofer (Ferric Derisomaltose)

Ferric derisomaltose, the active ingredient in Monofer, is an iron supplement presented as an injectable solution for intravenous use. It provides elemental iron to replenish depleted stores and supports hemoglobin synthesis, treating iron deficiency anemia in adults and children requiring rapid iron repletion. It is also indicated for patients with chronic kidney disease or those intolerant to oral iron therapy.

GNH India supplies Monofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Manufacturer / TM Owner

Pharmacosmos A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Monofer is used to treat iron deficiency anemia by replenishing iron stores.
  • Iron deficiency anemia: restores hemoglobin levels and repletes body iron stores.
  • Chronic kidney disease‑related anemia: provides intravenous iron when oral preparations are ineffective or not tolerated.
  • Pre‑operative anemia: raises hemoglobin before surgery to reduce the need for blood transfusion.

How It Works

  • Ferric derisomaltose is a stable iron‑carbohydrate complex that, after intravenous administration, is taken up by reticuloendothelial cells where the iron core is released. The released elemental iron binds to transferrin, is transported to the bone marrow, and is incorporated into developing hemoglobin, thereby restoring depleted iron stores.

Side Effects

Common Side Effects

  • Nausea: mild and transient.
  • Headache: occasional during or after infusion.
  • Injection site pain: discomfort at the infusion site.
  • Flushing: brief sensation of warmth or redness.
  • Dizziness: may occur during infusion.
  • Mild hypotension: temporary drop in blood pressure.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Severe hypotension: marked drop in blood pressure, potentially leading to shock.
  • Hypophosphatemia: significant reduction in serum phosphate levels.
  • Acute respiratory distress: difficulty breathing during or after infusion.
  • Cardiac arrest: rare but life‑threatening event.
  • Severe infusion reactions: including chest pain and bronchospasm.

Precautions & Warnings

  • Before initiating therapy, assess iron status and identify underlying causes of deficiency.
  • Monitor hemoglobin and ferritin levels during treatment to avoid iron overload.
  • Use caution in patients with known hypersensitivity to iron‑carbohydrate complexes.
  • Avoid rapid infusion rates; follow recommended administration guidelines.
  • Observe for signs of hypophosphatemia, especially in patients with renal impairment.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Major Interactions (Avoid)

  • Concurrent IV iron with other parenteral iron preparations: risk of iron overload.
  • Known hypersensitivity to dextran or other iron complexes: may trigger severe allergic reactions.

Moderate Interactions (Monitor Closely)

  • Oral phosphate binders: may alter phosphate balance; monitor serum phosphate.
  • Antacids containing aluminum or magnesium: could affect iron binding; observe for reduced efficacy.
  • Erythropoiesis‑stimulating agents: may enhance hemoglobin response; adjust monitoring accordingly.

Frequently Asked Questions

Monofer is an intravenous iron formulation indicated for the treatment of iron deficiency anemia. It is used when rapid replenishment of iron stores is needed, such as in patients who cannot tolerate oral iron or who have conditions like chronic kidney disease that limit oral absorption.

Ferric derisomaltose delivers elemental iron bound to a carbohydrate matrix. After intravenous infusion, the complex is taken up by macrophages, where iron is released, binds to transferrin, and is delivered to the bone marrow for incorporation into hemoglobin, thereby correcting the anemia.

The dose of Monofer is individualized. A prescribing clinician calculates the total iron deficit based on the patient’s weight, hemoglobin level, and target hemoglobin, then determines the appropriate volume to administer in a single or divided infusion.

Safety data for ferric derisomaltose in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Monofer, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Monofer delivers a high dose of elemental iron in a single infusion, reducing the number of administrations compared with some older IV iron formulations that require multiple smaller doses. Its carbohydrate‑bound structure is designed for controlled iron release, which may lower the incidence of acute infusion reactions relative to certain dextran‑based products.

Monofer should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Before use, allow the vial to reach room temperature if required by the administration protocol, and inspect for particulate matter or discoloration.

Monofer is given as an intravenous infusion. The product is diluted according to the manufacturer’s instructions and administered over a period that may range from a few minutes to an hour, depending on the total dose and patient tolerance. Infusion should be performed by qualified healthcare personnel in a setting equipped to manage potential reactions.

The most serious risks include severe hypersensitivity reactions such as anaphylaxis, marked hypotension, and rare cases of hypophosphatemia that can lead to muscle weakness or cardiac complications. Prompt recognition and treatment of these events are essential, and patients should be monitored during and after the infusion.

Monofer is contraindicated in individuals with a known hypersensitivity to ferric derisomaltose or any component of the formulation, as well as in patients with active systemic infections where iron could exacerbate bacterial growth. Caution is also advised for patients with severe liver disease or uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ferric Derisomaltose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT